B-LYMPHOCYTE chemoattractant (BLC/CXCL13): A potential novel disease activity marker of rheumatoid arthritis
Main Authors: | Pastor, I, Dickson, M, Binks, M, Lukey, P, Petavy, F, McClinton, C, Larche, M, Taylor, P |
---|---|
Format: | Conference item |
Published: |
2007
|
Similar Items
-
Between-group differences in ultrasonographic measures of synovitis and kinetics of response to oral steroids in active RA
by: Larche, M, et al.
Published: (2006) -
Quantitative power Doppler ultrasonography is a sensitive measure of metacarpophalangeal joint synovial vascularity in rheumatoid arthritis and declines significantly following a 2-week course of oral low-dose corticosteroids.
by: Larché, M, et al.
Published: (2010) -
Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment
by: Eman A. Baraka, et al.
Published: (2020-11-01) -
Retraction Note: Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment
by: Eman A. Baraka, et al.
Published: (2022-01-01) -
Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.
by: Seymour, M, et al.
Published: (2012)